Early cholesterol-lowering drug after heart attack
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a heart attack within the last 30 days, and it was your first hospitalization for it.
- You have blockages in at least two heart arteries, and the main blockage was treated with a stent or balloon.
- You have at least one other artery with a narrowing of 50% or more that is at least 2.5 mm wide.
- You are willing to take study medications and come for follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving a PCSK9 inhibitor (a strong cholesterol-lowering medicine) before a procedure to open blocked heart arteries can help patients who are having a heart attack. It may reduce damage and improve recovery.
This trial studies whether starting a cholesterol-lowering medicine called a PCSK9 inhibitor early after a heart attack can improve heart health and outcomes. It focuses on people who had a recent heart-artery procedure to fix the blockage in the left anterior descending (LAD) artery.
This trial studies whether starting a PCSK9-blocking medicine early after a specific type of heart attack can improve heart outcomes. You may be eligible if you have a STEMI heart attack soon, are planning a procedure to open the blocked artery, and meet safety and pregnancy criteria.
This trial tests giving strong cholesterol-lowering medicine within 24 hours after a heart attack to see if it helps recovery. It is for people who have had a recent heart attack and are getting a stent placed.
This study tests whether starting a cholesterol-lowering drug called a PCSK9 inhibitor soon after a heart attack can help prevent future blockages. If you had a heart attack, received a stent, and have other arteries with minor blockages, this trial may be for you.
This trial looks at when and how to use cholesterol-lowering treatment soon after a heart attack. It may help people lower LDL (“bad” cholesterol) safely in the first days after an acute event.
Hear when a new Acute Myocardial Infarction (AMI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.